Evotec - Research never stops
  • Loading...

Archive



Nov 09, 2009

Ad hoc: Evotec and Boehringer Ingelheim Extend and Broaden Research Collaboration

- read more
Sep 08, 2009

Ad hoc: Evotec starts Phase I with EVT 103, an NR2B-selective NMDA receptor antagonist

- read more
Aug 06, 2009

Ad hoc: Evotec Accelerates Growth Strategy of its Discovery Alliance Business with Acquisition of Indian RSIPL

- read more
Jun 29, 2009

Ad hoc: Evotec Announces the Successful Completion of the First Phase I Study with EVT 401

- read more
May 07, 2009

Ad hoc: Evotec Acquires Zebrafish Screening Operations of Summit Corporation

- read more
May 05, 2009

Ad hoc: Evotec to Re-engineer Drug Discovery and Development Operations

- read more
Apr 14, 2009

Ad hoc: Evotec Reports Results of Phase II Proof-of-Concept Study with EVT 302

- read more
Mar 27, 2009

Ad hoc: Evotec Restructures and Implements "Evotec 2012 - Action Plan to Focus and Grow"

- read more
Mar 09, 2009

Ad hoc: Evotec and Roche to Develop EVT 101 for Treatment-Resistant Depression

- read more
Mar 06, 2009

Ad hoc: Evotec Appoints Dr. Werner Lanthaler as Chief Executive Officer

- read more